Entheon Biomedical Announces EEG Patent Application & Provides Research Update Post published:December 16, 2021 Post category:Press Release
Psychiatrist and Addiction Researcher, Dr. Henry Kranzler Joins Entheon Advisory Board Post published:December 1, 2021 Post category:Press Release
Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs Post published:November 24, 2021 Post category:Press Release
Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study Post published:November 10, 2021 Post category:Press Release
Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials Post published:October 27, 2021 Post category:Press Release
Clinical Director of Imperial College’s Center for Psychedelic Research Joins Entheon Advisory Board Post published:August 25, 2021 Post category:Press Release
Entheon Biomedical Corp. Acquires Lobo Genetics Inc. Post published:July 30, 2021 Post category:Press Release
Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana Post published:June 30, 2021 Post category:Press Release
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave Post published:June 22, 2021 Post category:Press Release
Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc. Post published:June 16, 2021 Post category:Press Release